Skip to main content
Erschienen in: AIDS and Behavior 7/2023

03.01.2023 | Original Paper

A Capacity-Strengthening Intervention to Support HIV Pre-exposure Prophylaxis (PrEP) Awareness-Building and Promotion by Frontline Harm Reduction Workers in Baltimore, Maryland: A Mixed Methods Evaluation

verfasst von: Joseph G. Rosen, Leanne Zhang, Danielle Pelaez, Ju Nyeong Park, Jennifer L. Glick

Erschienen in: AIDS and Behavior | Ausgabe 7/2023

Einloggen, um Zugang zu erhalten

Abstract

Pre-exposure prophylaxis (PrEP) is a promising but underutilized HIV prevention tool among people who inject drugs (PWID). We developed and piloted an intervention to bolster PrEP promotion competencies among frontline harm reduction workers (FHRW) serving PWID clients in Baltimore, Maryland. Between December 2021 and February 2022, we developed and facilitated four trainings, which included didactic and practice-based/role-playing components, with 37 FHRW from four organizations. FHRW completed three structured surveys (pretest, posttest, 6-week posttest) and in-depth interviews (n = 14) to measure changes in PrEP promotion competencies attributable to training participation. PrEP knowledge and self-efficacy increased significantly (p < 0.001) from pretest to posttest, sustained through 6-week posttest. The proportion of FHRW discussing PrEP with clients doubled during the evaluation period (30–67%, p = 0.006). Feeling empowered to discuss PrEP and provision of population-tailored PrEP information were facilitators of PrEP promotion, while limited client interaction frequency/duration, privacy/confidentiality concerns, and anticipated PrEP stigma by clients inhibited PrEP promotion. Our capacity-strengthening intervention successfully increased PrEP knowledge, self-efficacy, and promotion among FHRW, affirming the adaptability and feasibility of integrating our training toolkit into FHRW practice across implementation settings.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
2.
Zurück zum Zitat Lyss SB, Buchacz K, McClung RP, Asher A, Oster AM. Responding to outbreaks of human immunodeficiency virus among persons who inject drugs—United States, 2016–2019: perspectives on recent experience and lessons learned. J Infect Dis. 2020;222(Supplement_5):S239-49.CrossRefPubMed Lyss SB, Buchacz K, McClung RP, Asher A, Oster AM. Responding to outbreaks of human immunodeficiency virus among persons who inject drugs—United States, 2016–2019: perspectives on recent experience and lessons learned. J Infect Dis. 2020;222(Supplement_5):S239-49.CrossRefPubMed
3.
Zurück zum Zitat Hojilla JC, Hurley LB, Marcus JL, Silverberg MJ, Skarbinski J, Satre DD, et al. Characterization of HIV preexposure prophylaxis use behaviors and HIV incidence among US adults in an integrated health care system. JAMA Netw Open. 2021;4(8): e2122692.CrossRefPubMedPubMedCentral Hojilla JC, Hurley LB, Marcus JL, Silverberg MJ, Skarbinski J, Satre DD, et al. Characterization of HIV preexposure prophylaxis use behaviors and HIV incidence among US adults in an integrated health care system. JAMA Netw Open. 2021;4(8): e2122692.CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Biello KB, Bazzi AR, Mimiaga MJ, Biancarelli DL, Edeza A, Salhaney P, et al. Perspectives on HIV pre-exposure prophylaxis (PrEP) utilization and related intervention needs among people who inject drugs. Harm Reduct J. 2018;15(1):1–12.CrossRef Biello KB, Bazzi AR, Mimiaga MJ, Biancarelli DL, Edeza A, Salhaney P, et al. Perspectives on HIV pre-exposure prophylaxis (PrEP) utilization and related intervention needs among people who inject drugs. Harm Reduct J. 2018;15(1):1–12.CrossRef
5.
Zurück zum Zitat Glick JL, Jivapong B, Russo R, Pelaez D, Piser R, Footer K, et al. Cultivating PEARL (promoting empowerment and risk reduction): formative research for a PrEP intervention among female sex workers in Baltimore. Maryland AIDS Behav. 2022;26(8):2664–75.CrossRefPubMed Glick JL, Jivapong B, Russo R, Pelaez D, Piser R, Footer K, et al. Cultivating PEARL (promoting empowerment and risk reduction): formative research for a PrEP intervention among female sex workers in Baltimore. Maryland AIDS Behav. 2022;26(8):2664–75.CrossRefPubMed
6.
Zurück zum Zitat Pleuhs B, Mistler CB, Quinn KG, Dickson-Gomez J, Walsh JL, Petroll AE, et al. Evidence of potential discriminatory HIV pre-exposure prophylaxis (PrEP) prescribing practices for people who inject drugs among a small percentage of providers in the U.S. J Prim Care Community Health. 2022;13:21501319211064000.CrossRef Pleuhs B, Mistler CB, Quinn KG, Dickson-Gomez J, Walsh JL, Petroll AE, et al. Evidence of potential discriminatory HIV pre-exposure prophylaxis (PrEP) prescribing practices for people who inject drugs among a small percentage of providers in the U.S. J Prim Care Community Health. 2022;13:21501319211064000.CrossRef
7.
Zurück zum Zitat Glick JL, Russo R, Jivapong B, Rosman L, Pelaez D, Footer KHA, et al. The PrEP care continuum among cisgender women who sell sex and/or use drugs globally: a systematic review. AIDS Behav. 2020;24(5):1312–33.CrossRefPubMedPubMedCentral Glick JL, Russo R, Jivapong B, Rosman L, Pelaez D, Footer KHA, et al. The PrEP care continuum among cisgender women who sell sex and/or use drugs globally: a systematic review. AIDS Behav. 2020;24(5):1312–33.CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Sherman SG, Schneider KE, Park JN, Allen ST, Hunt D, Chaulk CP, et al. PrEP awareness, eligibility, and interest among people who inject drugs in Baltimore, Maryland. Drug Alcohol Depend. 2019;195:148–55.CrossRefPubMed Sherman SG, Schneider KE, Park JN, Allen ST, Hunt D, Chaulk CP, et al. PrEP awareness, eligibility, and interest among people who inject drugs in Baltimore, Maryland. Drug Alcohol Depend. 2019;195:148–55.CrossRefPubMed
9.
Zurück zum Zitat Walters SM, Kral AH, Simpson KA, Wenger L, Bluthenthal RN. HIV pre-exposure prophylaxis prevention awareness, willingness, and perceived barriers among people who inject drugs in Los Angeles and San Francisco, CA, 2016–2018. Subst Use Misuse. 2020;55(14):2409–19.CrossRefPubMedPubMedCentral Walters SM, Kral AH, Simpson KA, Wenger L, Bluthenthal RN. HIV pre-exposure prophylaxis prevention awareness, willingness, and perceived barriers among people who inject drugs in Los Angeles and San Francisco, CA, 2016–2018. Subst Use Misuse. 2020;55(14):2409–19.CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Schneider KE, White RH, O’Rourke A, Kilkenny ME, Perdue M, Sherman SG, et al. Awareness of and interest in oral pre-exposure prophylaxis (PrEP) for HIV prevention and interest in hypothetical forms of PrEP among people who inject drugs in rural West Virginia. AIDS Care. 2021;33(6):721–8.CrossRefPubMed Schneider KE, White RH, O’Rourke A, Kilkenny ME, Perdue M, Sherman SG, et al. Awareness of and interest in oral pre-exposure prophylaxis (PrEP) for HIV prevention and interest in hypothetical forms of PrEP among people who inject drugs in rural West Virginia. AIDS Care. 2021;33(6):721–8.CrossRefPubMed
11.
Zurück zum Zitat Treloar C, Rance J, Yates K, Mao L. Trust and people who inject drugs: the perspectives of clients and staff of Needle Syringe Programs. Int J Drug Policy. 2016;27:138–45.CrossRefPubMed Treloar C, Rance J, Yates K, Mao L. Trust and people who inject drugs: the perspectives of clients and staff of Needle Syringe Programs. Int J Drug Policy. 2016;27:138–45.CrossRefPubMed
12.
Zurück zum Zitat Roth AM, Aumaier BL, Felsher MA, Welles SL, Martinez-Donate AP, Chavis M, et al. An exploration of factors impacting preexposure prophylaxis eligibility and access among syringe exchange users. Sex Transm Dis. 2018;45(4):217–21.CrossRefPubMed Roth AM, Aumaier BL, Felsher MA, Welles SL, Martinez-Donate AP, Chavis M, et al. An exploration of factors impacting preexposure prophylaxis eligibility and access among syringe exchange users. Sex Transm Dis. 2018;45(4):217–21.CrossRefPubMed
13.
Zurück zum Zitat Hershow RB, Gonzalez M, Costenbader E, Zule W, Golin C, Brinkley-Rubinstein L. Medical providers and harm reduction views on pre-exposure prophylaxis for HIV prevention among people who inject drugs. AIDS Educ Prev. 2019;31(4):363–79.CrossRefPubMedPubMedCentral Hershow RB, Gonzalez M, Costenbader E, Zule W, Golin C, Brinkley-Rubinstein L. Medical providers and harm reduction views on pre-exposure prophylaxis for HIV prevention among people who inject drugs. AIDS Educ Prev. 2019;31(4):363–79.CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Walters SM, Reilly KH, Neaigus A, Braunstein S. Awareness of pre-exposure prophylaxis (PrEP) among women who inject drugs in NYC: the importance of networks and syringe exchange programs for HIV prevention. Harm Reduct J. 2017;14(1):40.CrossRefPubMedPubMedCentral Walters SM, Reilly KH, Neaigus A, Braunstein S. Awareness of pre-exposure prophylaxis (PrEP) among women who inject drugs in NYC: the importance of networks and syringe exchange programs for HIV prevention. Harm Reduct J. 2017;14(1):40.CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Walters SM, Coston B, Neaigus A, Rivera AV, Starbuck L, Ramirez V, et al. The role of syringe exchange programs and sexual identity in awareness of pre-exposure prophylaxis (PrEP) for male persons who inject drugs. Int J Drug Policy. 2020;77: 102671.CrossRefPubMedPubMedCentral Walters SM, Coston B, Neaigus A, Rivera AV, Starbuck L, Ramirez V, et al. The role of syringe exchange programs and sexual identity in awareness of pre-exposure prophylaxis (PrEP) for male persons who inject drugs. Int J Drug Policy. 2020;77: 102671.CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Furukawa NW, Weimer M, Willenburg KS, Kilkenny ME, Atkins AD, Paul McClung R, et al. Expansion of preexposure prophylaxis capacity in response to an HIV outbreak among people who inject drugs-Cabell County, West Virginia, 2019. Public Health Rep. 2022;137(1):25–31.CrossRefPubMed Furukawa NW, Weimer M, Willenburg KS, Kilkenny ME, Atkins AD, Paul McClung R, et al. Expansion of preexposure prophylaxis capacity in response to an HIV outbreak among people who inject drugs-Cabell County, West Virginia, 2019. Public Health Rep. 2022;137(1):25–31.CrossRefPubMed
17.
Zurück zum Zitat Roth AM, Tran NK, Felsher M, Gadegbeku AB, Piecara B, Fox R, et al. Integrating HIV preexposure prophylaxis with community-based syringe services for women who inject drugs: results from the Project SHE Demonstration Study. J Acquir Immune Defic Syndr. 2021;86(3):e61-70.CrossRefPubMedPubMedCentral Roth AM, Tran NK, Felsher M, Gadegbeku AB, Piecara B, Fox R, et al. Integrating HIV preexposure prophylaxis with community-based syringe services for women who inject drugs: results from the Project SHE Demonstration Study. J Acquir Immune Defic Syndr. 2021;86(3):e61-70.CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Khandia R, Singhal S, Alqahtani T, Kamal MA, El-Shall NA, Nainu F, et al. Emergence of SARS-CoV-2 Omicron (B.1.1.529) variant, salient features, high global health concerns and strategies to counter it amid ongoing COVID-19 pandemic. Environ Res. 2022;209:112816.CrossRefPubMedPubMedCentral Khandia R, Singhal S, Alqahtani T, Kamal MA, El-Shall NA, Nainu F, et al. Emergence of SARS-CoV-2 Omicron (B.1.1.529) variant, salient features, high global health concerns and strategies to counter it amid ongoing COVID-19 pandemic. Environ Res. 2022;209:112816.CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Creswell JW, Clark VLP. Designing and conducting mixed methods research. Thousand Oaks: Sage; 2011. Creswell JW, Clark VLP. Designing and conducting mixed methods research. Thousand Oaks: Sage; 2011.
20.
Zurück zum Zitat Klein H, Washington TA. The pre-exposure prophylaxis (PrEP) stigma scale: preliminary findings from a pilot study. Int Public Health J. 2019;11(2):185–95.PubMedPubMedCentral Klein H, Washington TA. The pre-exposure prophylaxis (PrEP) stigma scale: preliminary findings from a pilot study. Int Public Health J. 2019;11(2):185–95.PubMedPubMedCentral
21.
Zurück zum Zitat Siegler AJ, Wiatrek S, Mouhanna F, Amico KR, Dominguez K, Jones J, et al. Validation of the HIV pre-exposure prophylaxis stigma scale: performance of likert and semantic differential scale versions. AIDS Behav. 2020;24(9):2637–49.CrossRefPubMedPubMedCentral Siegler AJ, Wiatrek S, Mouhanna F, Amico KR, Dominguez K, Jones J, et al. Validation of the HIV pre-exposure prophylaxis stigma scale: performance of likert and semantic differential scale versions. AIDS Behav. 2020;24(9):2637–49.CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Gale NK, Heath G, Cameron E, Rashid S, Redwood S. Using the framework method for the analysis of qualitative data in multi-disciplinary health research. BMC Med Res Methodol. 2013;13(1):117.CrossRefPubMedPubMedCentral Gale NK, Heath G, Cameron E, Rashid S, Redwood S. Using the framework method for the analysis of qualitative data in multi-disciplinary health research. BMC Med Res Methodol. 2013;13(1):117.CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Yin RK. Qualitative research from start to finish. New York: Guilford Press; 2010. Yin RK. Qualitative research from start to finish. New York: Guilford Press; 2010.
25.
Zurück zum Zitat Ayres L, Kavanaugh K, Knafl KA. Within-case and across-case approaches to qualitative data analysis. Qual Health Res. 2003;13(6):871–83.CrossRefPubMed Ayres L, Kavanaugh K, Knafl KA. Within-case and across-case approaches to qualitative data analysis. Qual Health Res. 2003;13(6):871–83.CrossRefPubMed
26.
Zurück zum Zitat Fetters MD. The mixed methods research workbook: activities for designing, implementing, and publishing projects. Thousand Oaks: SAGE Publications; 2019. Fetters MD. The mixed methods research workbook: activities for designing, implementing, and publishing projects. Thousand Oaks: SAGE Publications; 2019.
27.
Zurück zum Zitat Reback CJ, Clark KA, Rünger D, Fehrenbacher AE. A promising PrEP navigation intervention for transgender women and men who have sex with men experiencing multiple syndemic health disparities. J Community Health. 2019;44(6):1193–203.CrossRefPubMedPubMedCentral Reback CJ, Clark KA, Rünger D, Fehrenbacher AE. A promising PrEP navigation intervention for transgender women and men who have sex with men experiencing multiple syndemic health disparities. J Community Health. 2019;44(6):1193–203.CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat Blackstock OJ, Platt J, Golub SA, Anakaraonye AR, Norton BL, Walters SM, et al. A pilot study to evaluate a novel pre-exposure prophylaxis peer outreach and navigation intervention for women at high risk for HIV infection. AIDS Behav. 2021;25(5):1411–22.CrossRefPubMedPubMedCentral Blackstock OJ, Platt J, Golub SA, Anakaraonye AR, Norton BL, Walters SM, et al. A pilot study to evaluate a novel pre-exposure prophylaxis peer outreach and navigation intervention for women at high risk for HIV infection. AIDS Behav. 2021;25(5):1411–22.CrossRefPubMedPubMedCentral
29.
Zurück zum Zitat Tomko C, Park JN, Allen ST, Glick J, Galai N, Decker MR, et al. Awareness and interest in HIV pre-exposure prophylaxis among street-based female sex workers: results from a US context. AIDS Patient Care STDS. 2019;33(2):49–57.CrossRefPubMedPubMedCentral Tomko C, Park JN, Allen ST, Glick J, Galai N, Decker MR, et al. Awareness and interest in HIV pre-exposure prophylaxis among street-based female sex workers: results from a US context. AIDS Patient Care STDS. 2019;33(2):49–57.CrossRefPubMedPubMedCentral
30.
Zurück zum Zitat Pelaez D, Weicker NP, Glick J, Mesenburg JV, Wilson A, Kirkpatrick H, et al. The PEARL study: a prospective two-group pilot PrEP promotion intervention for cisgender female sex workers living in Baltimore, MD, U.S. AIDS Care. 2021;33(sup1):1–10.CrossRefPubMedPubMedCentral Pelaez D, Weicker NP, Glick J, Mesenburg JV, Wilson A, Kirkpatrick H, et al. The PEARL study: a prospective two-group pilot PrEP promotion intervention for cisgender female sex workers living in Baltimore, MD, U.S. AIDS Care. 2021;33(sup1):1–10.CrossRefPubMedPubMedCentral
31.
Zurück zum Zitat Cernasev A, Walker C, Armstrong D, Golden J. Changing the PrEP narrative: a call to action to increase PrEP uptake among women. Women. 2021;1(2):120–7.CrossRef Cernasev A, Walker C, Armstrong D, Golden J. Changing the PrEP narrative: a call to action to increase PrEP uptake among women. Women. 2021;1(2):120–7.CrossRef
Metadaten
Titel
A Capacity-Strengthening Intervention to Support HIV Pre-exposure Prophylaxis (PrEP) Awareness-Building and Promotion by Frontline Harm Reduction Workers in Baltimore, Maryland: A Mixed Methods Evaluation
verfasst von
Joseph G. Rosen
Leanne Zhang
Danielle Pelaez
Ju Nyeong Park
Jennifer L. Glick
Publikationsdatum
03.01.2023
Verlag
Springer US
Erschienen in
AIDS and Behavior / Ausgabe 7/2023
Print ISSN: 1090-7165
Elektronische ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-022-03971-4

Weitere Artikel der Ausgabe 7/2023

AIDS and Behavior 7/2023 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.